MAA
ENZ

Mraz Amerine & Associates’s Enzo Biochem, Inc. ENZ Stock Holding History

Mraz Amerine & Associates’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-18,100
Closed -$49K – 172
2019
Q1 		$49K Hold
18,100
– – 0.02% 159
2018
Q4 		$50K Buy
+18,100
New +$59.3K 0.02% 150

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mraz Amerine & Associates's ENZ Position: Q2 2019 in Review

Mraz Amerine & Associates sold out of Enzo Biochem, Inc. (ENZ) in Q2 2019, closing a stake of 18,100 shares — an estimated $49K sold.

Mraz Amerine & Associates first reported a position in ENZ in Q4 2018 and held it in 2 quarters. The position peaked at $50K in Q4 2018. 95 funds tracked by Wall St. Rank hold ENZ as of Q2 2019.

  • Mraz Amerine & Associates reported no remaining Enzo Biochem, Inc. position as of Q2 2019 after selling out during the quarter.
  • Mraz Amerine & Associates sold 18,100 Enzo Biochem, Inc. shares in Q2 2019, an estimated $49K.
  • Mraz Amerine & Associates first reported a position in Enzo Biochem, Inc. in Q4 2018 and held it in 2 quarters.
  • Mraz Amerine & Associates's Enzo Biochem, Inc. position peaked at $50K in Q4 2018.
  • 95 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2019.

Based on Mraz Amerine & Associates's 13F filing for Q2 2019, filed 2 Aug 2019.